Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Australia - Number of Births (‘000), 2013-2018
Figure 4-2: Australia - Number of Births by Mother’s Risk of Down’s syndrome (%), 2011
Figure 4-3: Australia - Potential Market in Three Different Scenarios (US$), 2013
Figure 4-4: Australia - NIPT Market (Million US$), 2013-2018
Figure 4-5: Australia - NIPT Market (Volume ‘000), 2013-2018
Figure 4-6: China - Number of Births (Million), 2013-2018
Figure 4-7: China - Potential Market in Two Different Scenarios (US$), 2012
Figure 4-8: China - NIPT Market (Million US$), 2013-2018
Figure 4-9: China - NIPT Market (Volume ‘000), 2013-2018
Figure 4-10: Japan - Number of Births (‘000), 2013-2018
Figure 4-11: Japan - Number of Births by Mother’s Risk of Down’s syndrome (%), 2010
Figure 4-12: Japan - Potential Market in Two Different Scenarios (US$), 2013
Figure 4-13: Japan - NIPT Market (Million US$), 2013-2018
Figure 4-14: Japan - NIPT Market (Volume ‘00), 2013-2018
Figure 4-15: India - Number of Births (Million), 2013-2018

List of Tables:

Table 3-1: Comparison of Features of Key NIPT Tests in APAC NIPT Market
Table 3-2: MaterniT21 PLUS Test Validation Results
Table 3-3: Verifi Test Validation Results
Table 3-4: Panorma Test Validation Results
Table 3-5: Harmony Test Validation Results
Table 3-6: NIFTY Test - Summary of Phase I Clinical Trial
Table 3-7: NIFTY Test - Summary of Phase II Clinical Trial
Table 3-8: Bambni Test - Summary of Phase I Clinical Trial
Table 3-9: Bambni Test - Summary of Phase II Clinical Trial
Table 3-10: Risk of Down’s syndrome with Rise in Maternal Age
Table 4-1: Australia - Number of Births by Age of Mother (2011)
Table 4-2: Australia NIPT Market Landscape - Players; Australian Partner; Cost per Test
Table 4-3: China NIPT Market Landscape - Players; Cost per Test
Table 4-4: Japan - Number of Births by Age of Mother (2010)
Table 4-5: Japan NIPT Market Landscape - Player; Cost per Test